Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to measure the impact of thyroid radiofrequency ablation procedure on patients with thyroid-related symptoms using a modified pre-existing scoring system.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Change in symptoms before and after ablation | Measured using a modified 6-item SYS questionnaire that objectively measures patient symptoms on a scale of 0=none, 1=moderate, 2=severe | Baseline and 1-, 3-, 6-, 12-, 18-, and 24-months following treatment |
Not provided
Not provided
Inclusion Criteria:
- Undergoing Radiofrequency Ablation (RFA) for symptomatic thyroid nodule(s).
Exclusion Criteria:
- Decline to participate in research.
Not provided
Not provided
Not provided
Adult patients undergoing ablation for symptomatic thyroid nodule(s)
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas Atwell, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013959 | Thyroid Diseases |
| ID | Term |
|---|---|
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided